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Abstract 
Reactive oxygen species (ROS) are implicated in vascular homeostasis. This study 
investigated whether O2
.-
, the foundation molecule of all ROS, regulates vasomotor function. 
Vascular reactivity was measured by isometric tension studies using thoracic aortas from 12-
14 week-old Sprague Dawley rats in the absence or presence of pyrogallol, an O2
.-
 generator. 
Pyrogallol significantly enhanced intracellular O2
.-
 level in a dose-dependent fashion without 
affecting the overall tissue viability. It also dose-dependently regulated both -adrenergic 
agonist-mediated contractility to phenylephrine and endothelium-dependent relaxations to 
acetylcholine. Pyrogallol improved and attenuated responses to acetylcholine at its lower (10 
nM - 1 M) and higher (10 - 100 M) concentrations, respectively while producing the 
inverse effects in response to phenylephrine at the same concentrations. The inactivation of 
nitric oxide synthase by L-NAME (50 M) abolished acetylcholine-induced vasodilatations 
but increased phenylephrine and KCl-induced vasoconstrictions irrespective of the 
concentration of the pyrogallol used. Relaxant responses to sodium nitroprusside, a nitric 
oxide donor, were not affected by pyrogallol. Other ROS i.e. peroxynitrite, H2O2 and 
hydroxyl radical that may be produced during experiments did not alter vascular functions. 
These findings suggest that the nature of O2
.-
-evoked vascular function is determined by its 
local concentration and the presence of a functional endothelium. 
 
Keywords: Superoxide anion; Endothelium; Acetylcholine; Relaxation; Contractility 
 
 
 
 
 
 3 
Introduction 
    The endothelium plays a pivotal role in the maintenance of normal vascular tone. However, 
its properties in pathological conditions change leading to a phenomenon termed “endothelial 
dysfunction” which is characterized by impaired endothelium-dependent relaxation 
(Bayraktutan, 2002). Endothelial dysfunction has been reported in conduit and resistance 
arteries of patients with vascular diseases including hypertension and in various animal 
models of human diseases (Panza et al., 1993; Taddei et al., 1993; Tesmafariam et al., 1988; 
Luscher et al., 1986). Despite current data on the etiology of endothelial dysfunction being 
rather diverse, much of the recent data have implicated oxidative stress in its pathogenesis 
(Ohara et al., 1993; Kerr et al., 1999). Oxidative stress is associated with enhanced production 
of reactive oxygen species (ROS) in particular superoxide anion (O2
.-
) that is normally 
converted to hydrogen peroxide (H2O2) by superoxide dismutases (SODs). H2O2 is in turn 
metabolized to H2O by antioxidant enzymes; catalase and glutathione peroxidase (Yu, 1994). 
However, in pathological states the balance between the synthesis and metabolism of ROS 
may be impaired thus leading to generation of oxidative stress. O2
.-
 can elicit direct 
vasoconstriction and scavenge nitric oxide (NO), the most potent endogenous vasodilator, to 
produce peroxynitrite (OONO
.-
) which oxidizes proteins, breaks DNA strands and reduces 
intracellular antioxidants such as glutathione and cysteine (Bayraktutan, 2002; Gryglewski et 
al., 1986). Contrary to these findings, other studies have revealed that low levels of O2
.-
 are 
required for normal vascular cell proliferation and migration and contribute to endothelium-
dependent vasodilatation in some vascular beds particularly after dismutation to H2O2 
(Bayraktutan, 2004; Bayraktutan, 2005; Wei et al., 1996). 
    In the light of these contradictory findings, the aim of the current study was to investigate 
whether local concentrations of O2
.-
 determine the nature of vascular functions using aortic 
rings from Sprague Dawley (SD) rats. To this end, relaxant responses to endothelium-
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(in)dependent agents and contractile responses to an -adrenergic agonist phenylephrine (PE) 
and receptor-independent constrictor KCl were investigated in vessels exposed to incremental 
concentrations of an O2
.-
-generating agent, pyrogallol. The requirement for an intact 
endothelium and the involvement of other ROS including H2O2 and OONO
.-
 in putative 
functional changes were also examined in the study. 
Materials and methods 
    All the experiments described in this article were performed in accordance with the UK 
“Home Office Guidance on the Operation of the Animals (Scientific Procedures) Act 1986”. 
Drugs and Chemicals 
    All drugs and chemicals, other than Mn(III)TMPyP (IDS Ltd., UK), used in this study were 
from Sigma Chemical Company (UK).  
Animals 
    The studies were conducted using the thoracic aortas obtained from 12-14 week old male 
SD rats. The aortas were removed from anticoagulated rats (100 U heparin, IV) under deep 
pentobarbitone sodium anesthesia (100 mg/kg body, IP) and carefully cleaned of adhering 
tissue. 
Vascular reactivity studies 
     Thoracic aortas were cut into six 2-3 mm rings and mounted horizontally on stainless 
hooks in 25 ml organ baths filled with carbonated (95% O2/5% CO2) Krebs buffer [in (mM): 
NaCl 118.3, KCl 4.7, MgSO4 1.2, KH2PO4 1.22, CaCl2 2.5, NaHCO3 25, glucose 11.1, pH 
7.4]. Rings were equilibrated for 90 min under 2 g resting tension and only one vasodilator 
was used for each ring experiment. Changes in isometric tension were detected and recorded 
by a force transducer and an 8 channel transducer data acquisition system (LE-TR201 and 
PowerLab/8S, ADInstruments), respectively. After initial equilibration period, ordinary Krebs 
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solution was replaced with fresh solution containing 1 M indomethacin to dismiss the 
relaxant effects of prostanoids. All experiments were performed in the latter solution. 
    At the beginning of each experiment dose-response curves to PE (0.003-10 M) were 
obtained. Rings were then washed and equilibrated prior to contraction with submaximal 
concentration of PE before detecting endothelium-dependent or endothelium-independent 
relaxant responses to acetylcholine (ACh, 0.03-1 M) and sodium nitroprusside (SNP, 0.01-
10 M), respectively. For contractility studies, the rings were incubated with cumulative 
concentrations of PE (0.003-10 M) or a single dose of KCl (120 mM) until the respective 
contractions reached a plateau. For pyrogallol experiments, rings that were used in the 
abovementioned experiments were washed and equilibrated prior to 20 min incubation with 
the required concentration of pyrogallol [C6H6O3; 1,2,3-trihydroxybenzene] and repetition of 
the same experiments. This experimental pattern allowed each vascular ring to serve as its 
own control for a given chemical. 
    At the end of each experiment, the rings were blotted dry, weighed and the lengths were 
measured to calculate tension as normalized for cross-sectional area as previously reported 
(Abebe et al., 1990). 
Detection of O2
.-
 
    O2
-
 generation in aortic rings was measured using three different approaches. Firstly, 
thoracic aortic rings (~10 mm) were placed in Krebs solution for 30 min at 37 °C prior to 
transfer into Krebs solution containing 5 M of lucigenin. The chemiluminescence was 
recorded every 60 seconds for 10 min using a luminometer and the levels of O2
.-
 were 
calculated by taking into account the differences in the readings before and after addition of 
the aortic segments to the buffer (Bayraktutan et al; 1998). 
    Secondly, level of O2
.-
 was measured by SOD-inhibitable cytochrome C reduction assay. 
Briefly, aortic homogenates were incubated with 50 µM cytochrome C for 60 min at 37 °C in 
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Krebs buffer with or without SOD (125 U/ml). Absorbances were recorded using a GENios 
plate reader (TECAN) at 550 nm with 60 seconds intervals for 8 min. Production of O2
.-
 was 
calculated as previously described and results were expressed as pmole O2
.-
 per mg tissue 
(Horie and Kita; 1994). 
    Finally, the level of O2
.-
 in aortic homogenates was measured using dihydroethidium 
(DHE) assay.  DHE is oxidized by O2
.-
 thereby yielding a fluorescent compound whose 
emission relates to the amount of O2
.-
 present in the system. This assay was performed in 96-
well microplates. Each well contained 100 μl of homogenate obtained from aortas (~10 mm) 
exposed to different concentrations of pyrogallol (10 nM -100 μM) in phosphate buffer (pH 
7.8) plus 10 μM of DHE in a volume of 100 μl of phosphate buffer. The reaction was 
performed at 25 °C and the extent of DHE oxidation was followed by measuring the increase 
of the fluorescence using a microplate reader for 60 min (excitation= 485 nm and emission= 
595 nm). Three independent experiments were performed for each concentration of 
pyrogallol. The percentage generation of fluorescence with aortic homogenates was calculated 
using the pyrogallol-untreated aortic homogenates as positive controls. 
Detection of H2O2 
    H2O2 synthesis was measured using 2',7'-dichlorodihydrofluorescein (DCHF) diacetate 
(DA) as a fluorescent probe for intracellular H2O2 measurement (López-Ongil et al; 1998). 
DCHF-DA diffuses readily to the intracellular
 
compartment, where it is desacetylated to the 
non-membrane-permeable
 
DCHF. Then, during the cellular production of H2O2, DCHF is 
oxidized
 
and emits a fluorescent signal. To this end, the normal and pyrogallol-incubated 
aortic segments were homogenised and loaded with 20 µM DCHF-DA for 30 min at 37 
o
C 
and fluorescence generation at 488 nm (excitation) and 525 nm (emission) was detected.
 
The 
fluorescent
 
signal was registered as a function of the time.  
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Detection of OONO
.- 
    Thoracic aortas were incubated with different concentrations of pyrogallol (10 nM- 100 
µM) in the presence of 20 µM 123-dihydrorhodamine (123-DHR) for 2 h at 37 
o
C in Krebs 
solution. Following incubation, 123-DHR conversion to 123-rhodamine was measured by 
fluorometric analysis at excitation/emission wavelengths of 485 and 530 nm, respectively. 
Fluorescence due to autooxidation of 123-DHR was deducted from the original measurements 
(Muijsers et al; 2000).  
LDH measurement 
    The vascular rings were exposed to different concentrations of pyrogallol in a 3 mL of 
phenol-free cell culture medium (DMEM) for 3 h at 37 °C in a humidified tissue culture 
incubator (5% CO2 / 95% air) prior to removal of an 100 µl of aliquot. The LDH release was 
measured spectrophotometrically from the changes in absorbance at 560 nm using 0.25 mM 
NADH and 0.75 mM pyruvate as substrates following subtraction of the background values 
obtained from the tubes without rings (Bergmeyer and Bernt; 1974). 
Statistical Analysis 
    Data are expressed as mean ± SEM. Each of the vascular reactivity was performed using 8 
rats. Dose-response curves were fitted by non-linear regression with simplex algorithm and 
Emax values, the maximum contractile response of the tissue that indicates the potency, were 
calculated. Relaxant responses were given as the percentages of PE precontraction. 
Comparisons of dose-response curves were evaluated by two-way analysis of variance 
(ANOVA) for repeated measures. Molecular biological experiments were performed using 
aortic samples from 3 different rats. Statistical significances for LDH release and ROS 
production were assessed by two-way ANOVA followed by Bonferroni-Dunn’s post hoc 
analysis. P values less than 0.05 were considered to be statistically significant. 
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Results 
Intracellular levels of O2
.-  
in aortic rings subjected to different levels of pyrogallol 
    In the current study, pyrogallol was employed as a generator of O2
.- 
as previously 
described. Pyrogallol produced significant dose-dependent increases in the levels of aortic O2
.-
 
as detected by lucigenin enhanced-chemiluminescence, cytochrome C reduction and DHE 
oxidation assays without altering the level of LDH release, an indicator of cellular damage 
(Table 1).  
Vasodilator responses in thoracic aortic rings and the effects of O2
.-
 on vascular relaxation 
    In PE-precontracted aortic rings, both ACh and SNP produced concentration-dependent 
relaxations and the inactivation of endothelium by mechanical (by rubbing) or 
pharmacological (via incubation with 50 M of L-NAME) means selectively inhibited 
endothelium-dependent but not endothelium-independent vascular relaxations (Fig. 1A-C). 
    Pyrogallol regulated endothelium-dependent relaxant responses in aortic rings in a dose-
dependent manner in that it improved and attenuated ACh-mediated relaxations at its lower 
(10 nM - 1 M) and higher (10 and 100 M) concentrations, respectively (Fig. 2A-B). 
However, pyrogallol did not affect relaxant responses to SNP. It is of note that the 
pharmacological and mechanical inactivation of endothelium selectively abrogated ACh- but 
not SNP-mediated relaxant responses in the presence of pyrogallol (data not shown).  
    To investigate whether pyrogallol-induced effects are attributable to its O2
.-
-releasing 
function, the aortic rings were pretreated with one of the two structurally different O2
.- 
scavengers, namely Tiron (4,5-dihydroxy-1,3-benzenedisulfonic acid, 1 M) or MPG 
(mercaptopropionylglycine, 1 M) for 20 min. Both agents prevented pyrogallol-mediated (10 
M) endothelium-dependent relaxations without affecting the basal relaxations determined in 
the absence of pyrogallol (Fig. 3A-B). To support these findings, experiments with exogenous 
SOD (150 U/ml) or an endogenous inhibitor of SOD, namely diethyldithiocarbamate 
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(DETCA, 1-10 mM) were conducted. Pretreatments with either agent alone for 20 min failed 
to alter the ACh-mediated relaxant responses while the combination of DETCA and 10 M 
pyrogallol worsened these responses and the SOD and pyrogallol combination was found to 
be ineffective (Fig. 3C-D). To establish whether the effects of low concentrations of 
pyrogallol are also mediated by O2
.-
, similar experiments were conducted in the presence of 
10 nM of pyrogallol where Tiron and MPG suppressed low dose pyrogallol-induced increases 
in ACh-mediated relaxant responses by almost 22% while DETCA and exogenous SOD 
failed to alter these responses in a significant manner. 
    Experiments performed under identical conditions with Tiron, MPG, SOD or DETCA 
revealed that none of these treatments had an impact on endothelium-independent relaxant 
responses. 
Elucidation of the putative involvement of other ROS in O2
.-
-mediated vascular relaxations 
    To examine the relative contributions of hydroxyl radical (
.
OH), H2O2 or OONO
.-
 that may 
be generated during incubation with pyrogallol to relaxant changes, the aortic rings were 
treated with two different inhibitors of each agent in the absence or presence of a lower (100 
nM) or a higher (10 M) concentration of pyrogallol. To this end, desferrioxamine (100 M) 
or DMSO (50 nM), catalase or glutathione peroxidase (100 U/ml for each agent) and 
Mn(III)TMPyP (10 M) or uric acid (100 M)  were used as inhibitors of .OH, H2O2 and 
OONO
.-
. It was revealed that none of these agents displayed significant effects on 
vasorelaxations. Figures 4A-C selectively show the effects of DMSO, catalase and 
Mn(III)TMPyP on ACh-mediated relaxations in the presence of 10 M of pyrogallol. To 
ensure whether pyrogallol treatments led to increases in intracellular levels of OONO
.-
 or 
H2O2, the levels of these ROS were measured in aortic vessels which showed steady increases 
to incremental concentrations of pyrogallol (Table 2). Given that OONO
.-
 or H2O2 (10 nM - 
100 M for each agent) per se produced dose-dependent increases in vascular relaxation in 
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vessels with or without endothelium (Fig. 5), it was safe to suggest that the pyrogallol-
mediated increases in OONO
.-
 or H2O2 did not reach the lower levels that were used in the 
latter experiments. Similar experiments with the listed inhibitors revealed their inefficacy in 
altering endothelium-independent relaxant responses to SNP. 
Effects of O2
.-
 on vascular contractility 
    PE (0.003-10 M) induced contractile responses in a dose-dependent manner in isolated 
aortic rings with or without endothelium (Fig. 6A). In endothelium-intact vascular rings, the 
lower concentrations of pyrogallol (10 nM - 1 M) diminished PE-mediated contractile 
responses - significantly between 1 nM to 1 M logarithmic concentrations of PE - without 
changing the Emax. However, the higher concentrations of pyrogallol (10 and 100 M) 
significantly enhanced PE-mediated contractility (Fig. 6B). Pretreatment of vascular rings 
with L-NAME (50 M) for 20 min significantly enhanced PE-mediated contractile responses 
regardless of the concentration of pyrogallol used (Fig. 6C). Similar to endothelium-intact 
rings, pyrogallol produced dose-dependent changes in endothelium-denuded aortic rings (data 
not shown). 
    The receptor-independent contractile responses of pyrogallol were determined through use 
of KCl (120 mM) that produced similar contractions in isolated aortic rings with or without 
endothelium in the absence or presence of pyrogallol (Fig. 7A-B). However, endothelial 
inactivation by L-NAME dramatically enhanced KCl-induced contractile responses in the 
presence of pyrogallol (Fig. 7C). 
Elucidation of the putative involvement of other ROS in O2
.-
-mediated vascular contractility 
    Tiron and MPG did not affect basal contractility to PE. However, they diminished 
pyrogallol-induced (10 M) contractile responses to PE by almost 50% (p<0.05). Inactivation 
of endothelium with L-NAME (50 M) did not influence inhibitory effects of these 
components on pyrogallol-evoked contractions (Fig. 8). In contrast to O2
.- 
scavengers, 
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treatments with exogenous SOD, DETCA, catalase, DMSO and Mn(III)TMPyP in the 
presence of pyrogallol (100 nM or 10 M) did not significantly affect PE-mediated contractile 
responses and generated between 3 to 5% difference in these responses. 
Discussion 
    Several factors including diminished production of NO due to inefficient utilization of 
substrate L-arginine or impaired activity of endothelial NO synthase have been implicated in 
the pathogenesis of endothelial dysfunction (Rodrigo et al., 1997; Liao et al., 1995; Goto et 
al., 2000). However, oxidative stress characterized by the excessive vascular presence of O2
.-
, 
has recently been associated with the pathogenesis of this phenomenon in a variety of diseases 
with vascular complications such as hypertension and hypercholesterolemia (Luscher et al., 
1986; Ohara et al., 1993). O2
.-
 under pathological conditions may trigger the formation of 
other ROS such as OONO
.-
, 
.
OH and H2O2 that exert opposing i.e. relaxant or contractile 
effects on endothelium through activating different pathways and/or modifying membrane 
permeability to macromolecules (Bayraktutan, 2002; Wei et al., 1996; Ellis et al., 2003; Gao 
et al., 2001; Shen et al., 2000; McQuaid et al., 1996). 
    Since the majority of the previous studies investigating the effects of ROS on vascular 
functions have focused mainly on exogenous H2O2 (Wei et al., 1996; Ellis et al., 2003; Gao et 
al., 2001; Shen et al., 2000; McQuaid et al., 1996; Lum et al., 2001), the current study aimed 
to investigate the direct effects of O2
.-
, the foundation molecule of all ROS, on vasomotor 
functions using aortas from SD rats. This study primarily demonstrated that pyrogallol, a 
potent O2
.-
-generator, produced significant dose-dependent increases in intracellular levels of 
O2
.-
 without affecting the tissue viability as determined by the measurements of LDH release. 
These findings were particularly important to ascertain that the putative differences that might 
be observed in the study would not be due to cellular damage. It also demonstrated that both 
ACh and SNP produced dose-dependent vasodilatations in aortic rings and that the 
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inactivation of endothelium by mechanical or pharmacological means selectively abolished 
relaxations to ACh thereby indicating the existence of a functional vascular smooth muscle 
layer following endothelial damage by either means. The investigation of the impact of O2
.-
 
on vasomotor function revealed that the endothelium-derived vasodilatations to ACh were 
improved and attenuated by lower (10 nM - 1 M) and higher (10 - 100 M) concentrations 
of pyrogallol, respectively and also that the inactivation of endothelium abrogated solely 
ACh-mediated responses regardless of the concentration of pyrogallol. Taken together these 
data implied a prerequisite for endothelial presence in modulation of beneficial activities of 
pyrogallol. This hypothesis was supported by the findings illustrating that the endothelial 
inactivation dramatically increased PE-induced contractile responses irrespective of the 
pyrogallol dose used despite initially recording significant decreases with lower 
concentrations (10 nM - 1M) of pyrogallol in PE-evoked contractility. 
    It is noteworthy here that the combination of PE and pyrogallol generated similar effects in 
endothelium-intact and -denuded rings, findings were in agreement with previous ones 
suggesting that the smooth muscle cells or 1-mediated responses may be the sites of action 
of O2
.-
 (Mizukawa et al., 1997; Gokce et al., 2005). Moreover, the additional contractility 
studies with KCl (120 mM) alone or with different doses of pyrogallol (10 nM - 100 M) 
produced similar contractions in vascular rings with or without endothelium. However, 
pretreatment of aortic rings with L-NAME significantly enhanced KCl-mediated contractile 
responses to pyrogallol selectively in endothelium-intact segments whereby indicated that the 
accentuation of pyrogallol-mediated contractility was due to endothelial inactivation but not 
to L-NAME itself. These data were rather surprising given that KCl induces smooth muscle 
contractions by depolarizing the cell membrane via a mechanism depending on calcium influx 
through the voltage-dependent channels (Karaki et al., 1997).  
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    It has been well-documented that NO is involved in much of the endothelium-derived 
vasodilatation and is readily neutralized by O2
.-
 (Bayraktutan, 2002; Gryglewski et al., 1986; 
Bellan et al., 1993). The direct correlation between O2
.-
 and vascular reactivity was further 
assessed in this study using O2
.-
 scavengers i.e. Tiron and MPG which prevented pyrogallol-
induced impairments in ACh-mediated relaxant responses without altering the basal 
endothelium-dependent relaxations. Nonetheless, while the beneficial effects of O2
.-
 
scavengers were not mimicked by exogenous SOD, an irreversible inhibitor of endogenous 
SOD i.e. DETCA worsened relaxant responses when used in combination with pyrogallol. 
These findings suggest that an increase in endogenous O2
.-
 stemmed from the inhibition of 
SOD alone is not sufficient to neutralize intracellular NO to deteriorate vascular relaxations. 
    It is inevitable that the incubation of aortic rings with pyrogallol would lead to generation 
of other ROS including 
.
OH, H2O2 and OONO
.-
. Indeed, exposure of aortas to incremental 
concentrations of pyrogallol produced steady increases in intracellular levels of both H2O2 
and OONO
.-
 levels. To investigate the contributions of these free radicals to vascular relaxant 
and contractile responses, the relevant experiments were repeated in the presence of the 
specific inhibitors of 
.
OH (DMSO; 50 nM or desferrioxamine; 100 M), H2O2 (catalase or 
glutathione peroxidise; 100 U/ml for each agent) or OONO
.-
 (Mn(III)TMPyP; 10 M or uric 
acid; 100 M) that failed to alter the vascular responses when used alone or in the presence of 
pyrogallol (100 nM or 10 M). In contrast, studies with OONO.- and H2O2 on vasculature 
showed that both agents could produce relaxations in a dose-dependent manner in vessels 
with or without endothelium thereby indicating direct vasodilatory effects of these 
compounds on smooth muscle cells. In previous studies, OONO
.-
-mediated relaxations have 
been assigned to elevation of cGMP levels, interference with Ca
2+
 movement and membrane 
hyperpolarization via K
+
-channel activation while those of H2O2 have been attributed to the 
NO synthesis and activation of smooth muscle K
+
 channels (Li et al., 2005; Gil-Longo et al., 
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2005). Although, the elucidation of the molecular mechanisms involved in O2
.-
-mediated 
vascular responses was out of the scope of the current study, it is possible that some of these 
mechanisms may be associated with O2
.-
-induced relaxant responses. In the current study, the 
inability of the ROS inhibitors to alter vascular responses may be explained by the existence 
of a delicate balance between their relaxant and contractile effects e.g. OONO
.-
, in addition to 
its vasodilator effects, also generates vascular contractions by reducing intracellular 
antioxidants including glutathione and oxidizing tetrahydrobiopterin, a critical cofactor for 
NO synthesis (Bayraktutan, 2002).  
    In summary, the major conclusions to be drawn from this study are firstly that the vascular 
relaxant and contractile functions are regulated by O2
.-
 in a dose-dependent fashion. The 
similar bimodal regulation of vascular function has previously been reported with H2O2 in 
endothelium-intact and endothelium-denuded rat aortas (Gil-Longo and Gonzalez-Vazquez, 
2005). Secondly, a functional endothelium is required for the regulation of O2
.-
-mediated 
dilator and contractile responses to ACh and PE, respectively. Finally, O2
.-
 may exert a direct 
effect on smooth muscle cells via stimulation of 1-adrenergic receptors. 
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 Fig. 1. (A) Acetylcholine (ACh)- and sodium nitroprusside (SNP)-induced relaxant 
responses in phenylephrine-precontracted aortic rings. Effects of mechanical and 
pharmacological (by L-NAME, 50 μM) inactivation of endothelium on ACh-induced (B) and 
SNP-induced (C) relaxations. Results are expressed as meanSEM from 8 separate 
experiments. *P<0.05 compared to endothelium-intact rings. 
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Fig. 2. (A) Effects of low dose pyrogallol (Pyro) on acetylcholine (ACh)-induced aortic relaxations. (B) Effects of high dose 
pyrogallol on ACh-induced aortic relaxations. Results are expressed as meanSEM from 8 separate experiments. *P<0.05 
compared to ACh-induced relaxations. 
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Fig. 3. Effects of O2
.-
-scavengers, Tiron (A) and MPG (B) and exogenous superoxide dismutase (SOD, C) and the inhibitor of SOD 
(DETCA, D) on acetylcholine (ACh)-induced aortic relaxations in the absence and presence of pyrogallol (Pyro). Results are expressed as 
meanSEM from 8 separate experiments. *P<0.05 compared to ACh-induced relaxations. 
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Fig. 4. Effects of DMSO (A), catalase (Cat, B) and Mn(III)TMPyP (C) on acetylcholine (ACh)-
induced aortic relaxations in the absence and presence of pyrogallol (Pyro). Results are expressed 
as meanSEM from 8 separate experiments. *P<0.05 compared to ACh-induced relaxations. 
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Fig. 5. Peroxynitrite (OONO
-
)- and hydrogen peroxide (H2O2)-induced relaxant 
responses in endothelium-intact [E(+)] and endothelium-denuded [E(-)] aortic rings. 
Results are expressed as meanSEM from 8 separate experiments.  
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Fig. 6. (A) Phenylpehrine (PE)-induced contractile responses in endothelium-intact [E(+)] and 
endothelium-denuded [E(-)] aortic rings. (B) Effects of different doses of pyrogallol (Pyro) on PE-
induced contractile responses in E(+) aortic rings. (C) Effect of pharmacological inactivation of 
endothelium by L-NAME (50 μM) on PE-induced contractility in the presence of different 
concentrations of pyrogallol in E(+) aortic rings. Results are expressed as meanSEM from 8 
separate experiments. 
*
P<0.05 compared to PE-mediated contractile responses in E(+). 
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Fig. 7. (A) KCl-induced aortic contractile responses in endothelium-intact [E(+)] aortic 
rings in the absence and presence of pyrogallol. (B) KCl-induced aortic contractile 
responses in endothelium-denuded [E(-)] aortic rings in the absence and presence of 
pyrogallol. (C) KCl-induced aortic contractile responses in L-NAME-treated E(+) in the 
absence and presence of pyrogallol. *P<0.05 compared to sole KCl-induced contractile 
response.  
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Table 1. Effect of different concentrations of pyrogallol on superoxide anion (O2
-
) generation and LDH release 
Pyrogallol Lucigenin chemiluminescence 
(RLU/g.min) 
Cytochrome C  
(pmol/mg tissue) 
DHE oxidation 
(increase in % generation) 
LDH release (~fold) 
None 30 ± 6.5 9 ± 1.3 1.0 ± 0.0 1.00 ± 0.00 
10 nM 100 ± 8.2
* 
36 ± 3.2
* 
24 ± 3.5 1.09 ± 0.11 
100 nM 176 ± 13.9
* 
89 ± 9.3
* 
33 ± 4.6 1.13 ± 0.10 
1 M 340 ± 17.7
* 
183 ± 14.4
* 
39 ± 7.5 1.05 ± 0.09 
10 M 786 ± 24.1
* 
326 ± 22.1
* 
63 ± 9.1 0.91 ± 0.12 
100 M 978 ± 31.6
* 
541 ± 27.3
* 
79 ± 9.9 0.93 ± 0.11 
 
The level of O2
-
 was measured in thoracic aortic rings using lucigenin-enhanced chemiluminescence, dihydroethidium (DHE) oxidation and superoxide dismutase-inhibitable 
cytochrome C reduction assays while the level of cellular injury was measured by lactate dehydrogenase (LDH) leakage into culture medium. Results are expressed as mean 
± SEM from three independent experiments. RLU; relative light unit.  
*
P<0.05, difference within each experimental group. 
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Table 2. Effect of different concentrations of pyrogallol on OONO
.-
 and H2O2 generation 
Pyrogallol 123-Rhodamine fluorescence 
(fold difference) 
2',7'-dichlorodihydrofluorescein oxidation 
(arbitrary units) 
None 1.0 ± 0.0 100  ± 0.0 
10 nM 1.12 ± 0.06
 
135 ± 8
* 
100 nM 1.26 ± 0.05
* 
144 ± 10
* 
1 M 1.37 ± 0.10
* 
166 ± 11
* 
10 M 1.43 ± 0.12
* 
187 ± 13
* 
100 M 1.51 ± 0.13
* 
205 ± 12
* 
 
The levels of OONO
.-
 and H2O2 were measured in thoracic aortic rings through detections of 123-rhodamine and 2',7'-dichlorodihydrofluorescein (DCHF) oxidations. Results 
are expressed as mean ± SEM from three independent experiments.  
*
P<0.05, difference to pyrogallol-untreated samples. 
 
 
